Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

ClinicalTrials.gov ID: NCT03598790

Public ClinicalTrials.gov record NCT03598790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to evaluate the long-term safety and tolerability of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis (PSO).

Study identification

NCT ID
NCT03598790
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
UCB Biopharma SRL
Industry
Enrollment
1,353 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 5, 2018 (Actual)
Primary completion
Nov 14, 2023 (Actual)
Completion
Nov 14, 2023 (Actual)
Last update posted
Apr 15, 2026

2018 – 2023

United States locations

U.S. sites
48
U.S. states
25
U.S. cities
46
Facility City State ZIP Site status
Ps0014 957 Glendale Arizona 85308 —
Ps0014 946 Phoenix Arizona 85032 —
Ps0014 910 Bakersfield California 93309 —
Ps0014 927 Los Angeles California 90033 —
Ps0014 919 San Diego California 92103 —
Ps0014 955 San Diego California 92123 —
Ps0014 943 San Luis Obispo California 93405 —
Ps0014 967 Santa Monica California 90404 —
Ps0014 934 Washington D.C. District of Columbia 20016 —
Ps0014 909 Boynton Beach Florida 33437 —
Ps0014 912 Coral Gables Florida 33134 —
Ps0014 928 Fort Myers Florida 33912 —
Ps0014 906 Hollywood Florida 33021 —
Ps0014 907 Miami Florida 33144 —
Ps0014 903 Ocala Florida 34470 —
Ps0014 921 Ormond Beach Florida 32174 —
Ps0014 936 Tampa Florida 33613 —
Ps0014 941 Alpharetta Georgia 30022 —
Ps0014 954 Skokie Illinois 60077 —
Ps0014 911 Plainfield Indiana 46168 —
Ps0014 900 West Des Moines Iowa 50265 —
Ps0014 905 Overland Park Kansas 66210 —
Ps0014 962 Owensboro Kentucky 42301 —
Ps0014 922 Baton Rouge Louisiana 70809 —
Ps0014 944 New Orleans Louisiana 70115 —
Ps0014 940 Beverly Massachusetts 01915 —
Ps0014 925 Brighton Massachusetts 02135 —
Ps0014 917 Troy Michigan 48084 —
Ps0014 915 Clayton Missouri 63105 —
Ps0014 958 Omaha Nebraska 68144 —
Ps0014 901 Portsmouth New Hampshire 03801 —
Ps0014 908 East Windsor New Jersey 08520 —
Ps0014 956 Verona New Jersey 07044 —
Ps0014 947 Buffalo New York 14221 —
Ps0014 965 Kew Gardens New York 11415 —
Ps0014 913 New York New York 10029-6501 —
Ps0014 963 Rochester New York 14623 —
Ps0014 961 Rocky Mount North Carolina 27804 —
Ps0014 932 Oklahoma City Oklahoma 73112 —
Ps0014 920 Portland Oregon 97210 —
Ps0014 929 Portland Oregon 97223 —
Ps0014 937 Johnston Rhode Island 02919 —
Ps0014 945 Greer South Carolina 29650 —
Ps0014 931 Dallas Texas 75231 —
Ps0014 924 Houston Texas 77004 —
Ps0014 914 San Antonio Texas 78213 —
Ps0014 951 Webster Texas 77598 —
Ps0014 933 Murray Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 141 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03598790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03598790 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →